Comparison of Patients With Coccidioidomycosis in Arizona Versus California: A Commercial Health Insurance Claims Analysis
- PMID: 40718545
- PMCID: PMC12290395
- DOI: 10.1093/ofid/ofaf405
Comparison of Patients With Coccidioidomycosis in Arizona Versus California: A Commercial Health Insurance Claims Analysis
Abstract
Commercially insured patients with coccidioidomycosis in Arizona (n = 1640) were more likely to have symptoms indicating acute pulmonary disease (eg, cough, dyspnea, chest pain) compared with patients in California (n = 701), who were more likely to have disseminated coccidioidomycosis, possibly reflecting differences in exposure, healthcare seeking, or clinical management.
Keywords: Arizona; California; Coccidioides; coccidioidomycosis.
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2025.
Conflict of interest statement
Potential conflicts of interest. G.R.T. has received research support and as a consultant for Astellas, Basilea, Cidara, F2G, GKS, Melinta, Mundipharma, Mayne, and Pfizer. F.M.D. has received research support by F2G. All other authors report no potential conflicts.
References
-
- Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med 2006; 119:964–9. - PubMed
LinkOut - more resources
Full Text Sources